The search for peripheral biomarkers for major depression: Benefiting from successes in the biology of smoking

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 3, 2014, Pages 230-234

  Philibert, Robert ^a,b   Gunter, Helen M ^b   Kolassa, Iris Tatjana ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Biomarker; Major depression; Substance use

Indexed keywords

BIOLOGICAL MARKER; SEROTONIN TRANSPORTER;

ARTICLE; BEHAVIOR GENETICS; COMORBIDITY; CORONARY ARTERY DISEASE; CPG ISLAND; DNA METHYLATION; ENDOPHENOTYPE; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF REPORT; SMOKING; SUBSTANCE USE; TOBACCO DEPENDENCE; TOBACCO USE; TREATMENT RESPONSE; AGE; ANIMAL; BLOOD; COGNITION; DEPRESSIVE DISORDER, MAJOR; ENVIRONMENTAL EXPOSURE; PHYSIOLOGY;

NICOTIANA TABACUM;

AGE FACTORS; ANIMALS; BIOLOGICAL MARKERS; COGNITION; DEPRESSIVE DISORDER, MAJOR; ENVIRONMENTAL EXPOSURE; HUMANS; SMOKING;

EID: 84897554726     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32227     Document Type: Article

References (35)

1. American Psychiatric Association. 1994. American Psychiatric Association. Diagnostic and statistical manual of mental disorder, 4th edition. Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5). Arlington: American Psychiatric Association Press.
3. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, Saccone NL, Saccone SF, Bertelsen S, Fox L, Horton WJ, Breslau N, Budde J, Cloninger CR, Dick DM, Foroud T, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Kuperman S, Madden PAF, Mayo K, Nurnberger J Jr, Pomerleau O, Porjesz B, Reyes O, Schuckit M, Swan G, Tischfield JA, Edenberg HJ, Rice JP, Goate AM. 2008. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171.
4. Boyd NR, Windsor RA, Perkins LL, Lowe JB. 1998. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern Child Health J 2:77-83.
5. Breslau N, Johnson EO, Hiripi E, Kessler R. 2001. Nicotine dependence in the united states: Prevalence, trends, and smoking persistence. Arch Gen Psychiatry 58:810-816.
6. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297:851-854.
7. Cutrona CE, Russell DW, Brown PA, Clark LA, Hessling RM, Gardner KA. 2005. Neighborhood context, personality, and stressful life events as predictors of depression among African American women. J Abnorm Psychol 114:3-15.
8. Dogan MV, Shields B, Cutrona C, Gao L, Gibbons FX, Simons R, Monick MM, Brody GH, Tan K, Beach SR, Philibert RA. 2014. The effect of smoking on DNA methylation of peripheral lymphocytes from African American women. BMC Genomics 15:151.
9. Flay BR. 1985. Psychosocial approaches to smoking prevention: A review of findings. Health Psychol 4:449-488.
10. Gibbons FX, Eggleston TJ. 1996. Smoker networks and the "typical smoker": A prospective analysis of smoking cessation. Health Psychol 15:469-477.
11. Guintivano J, Arad M, Gould T, Payne J, Kaminsky Z. 2013. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry. Online publication 21 May 2013; doi: 10.1038/mp.2013.62
12. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. 1991. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119-1127.
13. Karg K, Burmeister M, Shedden K, Sen S. 2011. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Arch Gen Psychiatry 68:444-454.
14. Kendler KS, Fiske A, Gardner CO, Gatz M. 2009. Delineation of two genetic pathways to major depression. Biol Psychiatry 65:808-811.
15. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLoS Med 5:e45.
16. Kolassa I-T, Ertl V, Eckart C, Glockner F, Kolassa S, Papassotiropoulos A, de Quervain D, Elbert T. 2010. Association study of trauma load and SLC6A4 promoter polymorphism in posttraumatic stress disorder: Evidence from survivors of the Rwandan genocide. J Clin Psychiatry 71:543-547.
17. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK, Heath AC, Madden PAF. 2004. Defining nicotine dependence for genetic research: Evidence from Australian twins. Psychol Med 34:865-879.
18. Manzardo AM, Henkhaus RS, Butler MG. 2012. Global DNA promoter methylation in frontal cortex of alcoholics and controls. Gene 498:5-12.
19. Mezuk B, Eaton WW, Albrecht S, Golden SH. 2008. Depression and type 2 diabetes over the lifespan. Diabetes Care 31:2383-2390.
20. Murphy SL, Xu J, Kochanek K. 2012. Deaths: Preliminary data for 2010. Rockville, MD: Centers for Disease Control, D. o. V. S.
21. Nestler EJ, Hyman SE. 2010. Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-1169.
22. Owen L, McNeill A. 2001. Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction 96:1001-1006.
23. Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J, Bridge J, Blizinsky K, Dennis K, Vedell P, Churchill GA, Redei EE. 2012. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry 2:e101.
24. Philibert RA, Beach SR, Brody GH. 2012a. Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Epigenetics 7:1331-1338.
25. Philibert RA, Plume JT, Gibbons FX, Brody GH, Beach SRH. 2012b. The impact of recent alcohol use on genome wide DNA methylation signatures. Front Gene 3:54. doi: 10.3389/fgene.2012.00054
26. Philibert R, Beach SR, Li K-M, Brody G. 2013. Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clin Epigenet 5:19-26.
27. Risch N, Herrell R, Lehner T, Liang K-Y, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR. 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. JAMA 301:2462-2471.
28. Rizzo M, Robinson S, Neale V. 2007. The brain in the wild. In: Parasuraman R, Rizzo M, editors. Neuroergonomics: the brain at work. New York: Oxford University Press; pp. 113-128.
29. Sasayama D, Wakabayashi C, Hori H, Teraishi T, Hattori K, Ota M, Ishikawa M, Arima K, Higuchi T, Amano N, Kunugi H. 2011. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients. J Psychiatr Res 45:1439-1444.
30. Schmidt HD, Shelton RC, Duman RS. 2011. Functional biomarkers of depression: Diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 36:2375-2394.
31. Sim SC, Ingelman-Sundberg M. 2011. Pharmacogenomic biomarkers: New tools in current and future drug therapy. Trends Pharmacol Sci 32:72-81.
32. Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, Jones L, Murrah NV, Goldberg J, Vaccarino V. 2009. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: The twins heart study. Psychosom Med 71:152-158.
33. Tsuang M, Francis T, Minor K, Thomas A, Stone W. 2012. Genetics of smoking and depression. Hum Genet 131:905-915.
34. Windsor RA, Lowe JB, Perkins LL, Smith-Yoder D, Artz L, Crawford M, Amburgy K, Boyd NR Jr. 1993. Health education for pregnant smokers: Its behavioral impact and cost benefit. Am J Public Health 83:201-206; 1694576.
35. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. 2007. Diagnostic accuracy of the mood module of the patient health questionnaire: A systematic review. Gen Hosp Psychiatry 29:388-395.